The study, published in the American Journal of Health Promotion, demonstrated that clinically obese patients can lose weight in just three visits with virtual health coaching
LOS ANGELES, CA – July 29, 2020 – inHealth, a Lifestyle Therapeutics company with a mission to unlock the human potential for preventing and reversing chronic disease, today announced the publication of a new study demonstrating that telehealth-enabled lifestyle therapy is an effective benefit and helps employees, whether overweight or obese, lose weight quickly. The new study was published in the American Journal of Health Promotion (AJHP) and builds on a body of research backing lifestyle treatment as effective medicine.
“COVID-19 has created an environment where the pace of disease progression and mental health is challenging employers’ ability to protect their most important asset; the health and wellbeing of their employees,” said Harry Kim, Executive Chairman and CEO, inHealth Lifestyle Therapeutics. “Employers are seeking telehealth-enabled, clinically validated programs to improve the health of their employees and bend the cost curve. This study expands the clinical evidence and impact of inHealth’s Lifestyle Therapeutics as a compelling and necessary response to support our workforce.”
In the study published in AJHP, researchers looked at the efficacy of virtual lifestyle therapy delivered by inHealth specifically for weight loss for clinically overweight and obese patients within a large, national employer group. The study enrolled 685 participants: 296 women of which 64 percent were obese and 389 men of which 62 percent were obese. Results demonstrated that, on average, men and women combined lost three percent of their weight in just three sessions; patients with a higher initial BMI (obese) lost over four percent of their weight.
Although not captured in the AJHP study, these findings are consistent with past research conducted by inHealth Lifestyle Therapeutics offering compelling evidence that integrating lifestyle therapy into clinical treatment plans produces significant patient outcomes. The company has previously demonstrated long-term results for patients in improving hypertension, diabetes and weight loss. For example, a past clinical investigation conducted by inHealth showed that, with lifestyle therapy, 78 percent of patients with hypertension or pre-hypertension became pre-hypertensive or normal in just three visits.
According to the Centers for Disease Control and Prevention, more than 40 percent of the American population struggles with obesity. Obesity is a risk factor for other chronic diseases such as heart disease, stroke, type 2 diabetes, and certain types of cancer. Amid the COVID-19 pandemic, obesity has also been identified as a risk factor for complications from the virus. With inHealth Lifestyle Therapeutics, employers can deliver a benefit to their employees that will help them manage obesity, and other chronic diseases, and reduce their risk of complications from coronavirus.
For more information on inHealth’s clinical research, virtual Lifestyle Therapeutics and work with employers, please visit www.inhealthonline.com.
About inHealth Lifestyle Therapeutics
We are a Lifestyle Therapeutics company with a mission to unlock the human potential for preventing and reversing chronic disease. Our clinically validated, virtual solutions are scientifically proven to activate and sustain long-term patient outcomes, and delivered by trained, clinical health coaches. Our Lifestyle Therapeutics can be prescribed by physicians, covered by most insurance, and delivered through our partnerships with clinicians, health plans, employers, and medical device and digital health innovators. Like our services, we are a virtual company with team members all over the U.S., and we are hiring. To learn more, visit www.inhealthonline.com.